![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/4-Table1-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Table 1 from Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. | Semantic Scholar
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Journal of the COPD Foundation Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient-Powered Research N
VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions | 2 Minute Medicine
Pharmacological management of COPD .SABA = short-acting beta 2... | Download Scientific Diagram
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
drugs-respiratory1.ppt
Inhaled bronchodilators for chronic bronchitis and emphysema - Document - Gale Academic OneFile
Muscarinic Antagonist - an overview | ScienceDirect Topics
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis | BMC Pulmonary Medicine | Full Text
Muscarinic Antagonists - AlphaNet
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Follow-up treatment of COPD patients. Abbreviations: laMa, long-acting... | Download Scientific Diagram
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Asthma Drugs - Muscarinic Antagonists (Ipratropium) - YouTube
Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future
Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis | Journal of Investigative Medicine
